Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
67.51
-2.27 (-3.25%)
At close: Apr 28, 2026, 4:00 PM EDT
67.51
0.00 (0.00%)
After-hours: Apr 28, 2026, 7:00 PM EDT

Company Description

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.

It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V.

site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers.

The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs.

The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms.

The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce.

Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Solventum Corporation
Solventum logo
Country United States
Founded 2023
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 20,584
CEO Bryan Hanson

Contact Details

Address:
1750 Yankee Doodle Road
Eagan, Minnesota 55121
United States
Website solventum.com

Stock Details

Ticker Symbol SOLV
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001964738
CUSIP Number 83444M101
ISIN Number US83444M1018
Employer ID 92-2008841
SIC Code 3841

Key Executives

Name Position
Bryan C. Hanson Chief Executive Officer and Director
Wayde D. McMillan Executive Vice President and Chief Financial Officer
Amy Landucci Chief Information and Digital Officer
Marcela A. Kirberger Chief Corporate and Legal Affairs Officer & Corporate Secretary
Heather L. Knight Chief Commercial Officer
Mary T. Wilcox Senior Vice President, Corporate Controller and Chief Accounting Officer
Amy Wakeham Senior Vice President of Investor Relations and External Finance Communications
Kate Dobbs Chief Communications and Corporate Marketing Officer
Rachel H. Ellingson Chief Strategy and Corporate Development Officer
Tammy L. Gomez Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Mar 27, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 27, 2026 DEF 14A Other definitive proxy statements
Mar 27, 2026 SCHEDULE 13G/A Filing
Mar 24, 2026 8-K Current Report
Feb 27, 2026 10-K Annual Report
Feb 26, 2026 8-K Current Report
Jan 27, 2026 SCHEDULE 13G/A Filing
Dec 16, 2025 8-K Current Report
Nov 13, 2025 SCHEDULE 13G/A Filing
Nov 6, 2025 10-Q Quarterly Report